Cyclin D1 mediated by the nuclear translocation of nuclear factor kappa B exerts an oncogenic role in lung cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249.
   PubMed Web of Science ®Google Scholar
• Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389:299–311.
   PubMed Web of Science ®Google Scholar
• Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893:1–19.
   PubMed Web of Science ®Google Scholar
• Gautschi O, Ratschiller D, Gugger M, et al. Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. Lung Cancer. 2007;55:1–14.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Connolly T, Futcher B, et al. Human D-type cyclin. Cell. 1991;65:691–699.
   PubMed Web of Science ®Google Scholar
• Al-Qasem A, Al-Howail HA, Al-Swailem M, et al. PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition. Mol Carcinog. 2016;55:233–244.
   PubMed Web of Science ®Google Scholar
• Guo F, Fu Q, Wang Y, et al. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis. J Cell Mol Med. 2019;23:5907–5919.
   PubMed Web of Science ®Google Scholar
• Wang M, Yu W, Gao J, et al. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1. J Cell Physiol. 2020;235:1588–1600.
   PubMed Web of Science ®Google Scholar
• Wu SY, Lan SH, Liu HS. Degradative autophagy selectively regulates CCND1 (cyclin D1) and MIR224, two oncogenic factors involved in hepatocellular carcinoma tumorigenesis. Autophagy. 2019;15:729–730.
   PubMed Web of Science ®Google Scholar
• Bushweller JH. Targeting transcription factors in cancer - from undruggable to reality. Nat Rev Cancer. 2019;19:611–624.
   PubMed Web of Science ®Google Scholar
• Bollaert E, de Rocca Serra A, Demoulin JB. The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathways. Cell Mol Life Sci. 2019;76:1529–1539.
   PubMed Web of Science ®Google Scholar
• Lin Y, Bai L, Chen W, et al. The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets. 2010;14:45–55.
   PubMed Web of Science ®Google Scholar
• Chen W, Li Z, Bai L, et al. NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target. Front Biosci (Landmark Ed). 2011;16:1172–1185.
   PubMed Web of Science ®Google Scholar
• Ramos-Garcia P, Gil-Montoya JA, Scully C, et al. An update on the implications of cyclin D1 in oral carcinogenesis. Oral Dis. 2017;23:897–912.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Ali H, Du Z, Li X, et al. Identification of suitable reference genes for gene expression studies using quantitative polymerase chain reaction in lung cancer in vitro. Mol Med Rep. 2015;11:3767–3773.
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Takeuchi T, Ueda K, et al. Detection of eight antibodies in cancer patients’ sera against proteins derived from the adenocarcinoma A549 cell line using proteomics-based analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;838:15–20.
   PubMed Web of Science ®Google Scholar
• Sun YX, Dai DK, Liu R, et al. Therapeutic effect of SN50, an inhibitor of nuclear factor-kappaB, in treatment of TBI in mice. Neurol Sci. 2013;34:345–355.
   PubMed Web of Science ®Google Scholar
• Xie J, Shen K, Lenchine RV, et al. Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis. Int J Cancer. 2018;142:1865–1877.
   PubMed Web of Science ®Google Scholar
• Zhuang X, Dong A, Wang R, et al. Ursolic acid benzaldehyde chalcone, leads to inhibition of cell proliferation and arrests cycle in G1/G0 phase in colon cancer. Saudi J Biol Sci. 2018;25:1762–1766.
   PubMed Web of Science ®Google Scholar
• Yang L, Liu L, Gao H, et al. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis. J Hematol Oncol. 2017;10:159.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Ren X, Lu X, et al. GZD856, a novel potent PDGFRalpha/beta inhibitor, suppresses the growth and migration of lung cancer cells in vitro and in vivo. Cancer Lett. 2016;375:172–178.
   PubMed Web of Science ®Google Scholar
• He S, Chen M, Lin X, et al. Triptolide inhibits PDGF-induced proliferation of ASMCs through G0/G1 cell cycle arrest and suppression of the AKT/NF-kappaB/cyclinD1 signaling pathway. Eur J Pharmacol. 2020;867:172811.
   PubMed Web of Science ®Google Scholar
• Moradi Binabaj M, Bahrami A, Khazaei M, et al. The prognostic value of cyclin D1 expression in the survival of cancer patients: a meta-analysis. Gene. 2020;728:144283.
   PubMed Web of Science ®Google Scholar
• Seiler R, Thalmann GN, Rotzer D, et al. CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response. Mod Pathol. 2014;27:87–95.
   PubMed Web of Science ®Google Scholar
• Qie S, Diehl JA. Cyclin D1, cancer progression, and opportunities in cancer treatment. J Mol Med (Berl). 2016;94:1313–1326.
   PubMed Web of Science ®Google Scholar
• Hu X, Wang P, Qu C, et al. Circular RNA Circ_0000677 promotes cell proliferation by regulating microRNA-106b-5p/CCND1 in non-small cell lung cancer. Bioengineered. 2021;12:6229–6239.
   PubMed Web of Science ®Google Scholar
• Wu C, Zhu XT, Xia L, et al. High expression of long noncoding RNA PCNA-AS1 promotes non-small-cell lung cancer cell proliferation and oncogenic activity via upregulating CCND1. J Cancer. 2020;11:1959–1967.
   PubMed Web of Science ®Google Scholar
• Yang Y, Lu T, Li Z, et al. FGFR1 regulates proliferation and metastasis by targeting CCND1 in FGFR1 amplified lung cancer. Cell Adh Migr. 2020;14:82–95.
   PubMed Web of Science ®Google Scholar
• Zhao M, Xu P, Liu Z, et al. Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/beta-catenin signaling in non-small-cell lung cancer. Cell Death Dis. 2018;9:78.
   PubMed Web of Science ®Google Scholar
• Zhao W, Hu JX, Hao RM, et al. Induction of microRNAlet7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1. Oncol Rep. 2018;40:1843–1854.
   PubMed Web of Science ®Google Scholar
• You W, Chen B, Liu X, et al. Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1. Sci Rep. 2017;7:591.
   PubMed Web of Science ®Google Scholar
• Li Y, Xiao X, Chen H, et al. Transcription factor NFYA promotes G1/S cell cycle transition and cell proliferation by transactivating cyclin D1 and CDK4 in clear cell renal cell carcinoma. Am J Cancer Res. 2020;10:2446–2463.
   PubMed Web of Science ®Google Scholar
• Batra S, Balamayooran G, Sahoo MK. Nuclear factor-kappaB: a key regulator in health and disease of lungs. Arch Immunol Ther Exp (Warsz). 2011;59:335–351.
   PubMed Web of Science ®Google Scholar
• Wu D, Wu P, Zhao L, et al. NF-kappaB expression and outcomes in solid tumors: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94:e1687.
   PubMed Web of Science ®Google Scholar
• Liang ZQ, Wang X, Li LY, et al. Nuclear factor-kappaB-dependent cyclin D1 induction and DNA replication associated with N-methyl-D-aspartate receptor-mediated apoptosis in rat striatum. J Neurosci Res. 2007;85:1295–1309.
   PubMed Web of Science ®Google Scholar
• Yan W, Cheng L, Zhang D. Ultrasound-Targeted microbubble destruction mediated si-CyclinD1 inhibits the development of hepatocellular carcinoma via suppression of PI3K/AKT signaling pathway. Cancer Manag Res. 2020;12:10829–10839.
   PubMed Web of Science ®Google Scholar
• Prasad SB, Yadav SS, Das M, et al. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer. Cell Oncol (Dordr). 2015;38:215–225.
   PubMed Web of Science ®Google Scholar